From a6cba602ef3ed1288c9337b17f938bfda1cd70cf Mon Sep 17 00:00:00 2001 From: borja Date: Wed, 30 Oct 2024 15:34:52 +0100 Subject: [PATCH] Auto saved by Logseq --- pages/InCORNTD 2025___Application.md | 7 +++++-- 1 file changed, 5 insertions(+), 2 deletions(-) diff --git a/pages/InCORNTD 2025___Application.md b/pages/InCORNTD 2025___Application.md index 19a1c680..f982d5aa 100644 --- a/pages/InCORNTD 2025___Application.md +++ b/pages/InCORNTD 2025___Application.md @@ -1,7 +1,10 @@ # [[2024/10/30]] - **Título**: Fixed dose albenzadole/ivermectin coformulation, an innovative tool to help countries achieve their NTD control goals in a post-donation era - - **Description**: The fixed-dose coformulation of albendazole and ivermectin is the result of 10+ years of innovations carried out by African and European organizations working through public-private partnerships. + - #+BEGIN_VERSE + **Description**: The fixed-dose coformulation (FDC) of albendazole and ivermectin is the result of more than years of innovations carried out by African and European organizations working through public-private partnerships. + This orodispersible, mango-flavoured tablet has already demonstrated safety and efficacy against soil-transmitted helminths in a 2022/2023 phase II/III pivotal trial and is currently under evaluation by the European Medicines Agency (EMA) under the EU-M4All procedure and Ghana's FDA for registration. + The fixed-dose combination of albendazole and ivermectin provides a novel approach to mass drug administration campaigns that simplifies logistics while providing control abilities for more parasites. It allows for a more targeted approach -- + #+END_VERSE - \ No newline at end of file